chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started with mild headache, mild nausea, then pounding, bounding pulse of about 80 (my resting is usually 60) THIS WAS THE SYMPTOM THAT MOST CONCERNED ME AS I HAVE A DILATED ASCENDING THORACIC AORTA)  chills intermittent on first day required heat, blankets, 2nd day (yesterday) chills were intermittent throughout the day; a feeling of "foggy brain", fatigued muscles especially thighs, aching joints, aching muscles, unable to fix a meal or to stand for long, considered calling for help, but no fever, no breathing difficulty, just rested, slept off and on 17 hours first day, yesterday normal sleep, today feel fine, so glad this has resolved!  My adult disabled son had NO symptoms for first or second shot.  I had no symptoms at FIRST shot.  This SECOND ONE WAS A DOOZY!
Very tired beginning about 10 hours after injection.  Tired for about 24 hours (tired, as in sleepy, not physically exhausted) and then felt fine.
Patient complaining of continued discomfort on injection site. He said a nurse who he knows advised him it may be a high injection. He has not seen his doctor about the injection yet, but is planning on it.
Pt reported CP., dizziness, and altered vision. Pt was observed for an additional 15 minutes. After observation, pt reported relief from all complaints.
Swelling at site x2 days, sl tenderness, warmth, no induration, site approx 3cm x 6 cm. Pt well appearing, cool compress, ibuprofen advised.
p/vax pt c/o of lump in back of throat;no swelling noted by MD;sweating was noted;BP 180/90-130/90;
Vesiculosullous rash, asthenia, fatigue, skin erythema - Information has been received from a physician's assistant concerning a 46 year old caucasian male who on 17 Jun 2000 was vaccinated with one dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot 16765 reported - invalid lot number) IM in the right deltoid.  On 18 Jun 2000 the patient experienced a papulovesicular rash on the neck and trunk and erythema.  The patient was afebrile.  The patient also experienced tiredness.  There were no lymph nodes involved.  Laboratory tests indicated a rubella titer was negative. A strep culture was negative.  On 21 Jun 2000 the patient recovered.  No further information is available.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender (encounter key #370205). The patient's concurrent conditions and medical history were not provided. On 07-OCT-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 0.5 mL (VIs 10 SDV) (Lot # K007822, expiration date 15-AUG-2015) single dose, route and anatomical location were not provided. There was no concomitant medication provided. No adverse effects were reported. On an unknown date, PNEUMOVAX had a temperature excursion for 72 hours, the lowest recorded temperature was 28F (-2.222 Celsius). The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". There was no product quality complaint involved. This is one of several cases received from the same reporter. Additional information has been requested.
Quick immune response. Heart rate went up- per FitBit. Chest pain, pressure going to back. Heart rate got better only when resting.
Patient developed a red rash over all of her body that lasted 4 full months. She was treated with steroid cream.
Rash and swelling. Diphenhydramine 50 mg TID, naproxen 500 mg BID.
Colitis, bloody diarrhea, duodenitis, gastritis, fever within 48 hours of receiving vaccine (ROTATEQ).
pt recvd Imovax instead of immune globulin; some of the vax was injected around the wound; subsequently pt was given the correct dose of immune globulin; pt had brough the vax into ER & someone gave it incorrectly;
tingling and cramps in left hand..cramps went away, tingling is better but remains in left hand...two bumps in left hand
The patient (one of our pharmacy technicians) was given the vaccine because she is a smoker. There was injection site pain immediately after administration at around 10:45 AM. Over the next few hours the pain worsened. By about 1:30 PM the patient noticed their arm was swollen, red, and rated the pain a 9/10. She took a 200 mg ibuprofen. There were no other symptoms outside of the injection site. I drove the patient to an urgent care clinic where she was given a steroid injection with lidocaine. She was also given a prescription for cetirizine and a three day course of steroids to take by mouth.
PATIENT EXPERIENCED FEVER, CHILLS, JOINT ACHES, SEVERE HEADACHE, NAUSEA, DULL ACHE IN LEFT EYE (SAME EYE AFFECTED WHEN SHE HAD SHINGLES BEFORE).
Raised red rash below the injection site on the left arm, warm to the touch.  Continued to spread across outside of bicep area 29-48 hours after injection.  Painful to the touch for approximately 72 hours after injection.  Covered approximately a 3" x 4" area of the arm.
14NOV90 tingling & cold hands & feet; 16NOV90 Seen by MD tingling, hypersensitive to touch, no response to knee reflex, tired; 22NOV90 unable to eat much, trouble ambulating, slurred speech, vision problems; poss GBS, backache, low BP;
Hot Sweats; she has a headache without fever; Bad diarrhea; vomiting; fever; This spontaneous case was reported by a nurse and describes the occurrence of HYPERHIDROSIS (Hot Sweats), DIARRHOEA (Bad diarrhea), VOMITING (vomiting), PYREXIA (fever) and HEADACHE (she has a headache without fever) in a 77-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Flu Vaccine (Flu 2 weeks before the Spikevax). Past adverse reactions to the above products included No adverse event with Flu Vaccine. Concurrent medical conditions included Hypertension.    On 26-Oct-2023, the patient received fifth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 27-Oct-2023, the patient experienced DIARRHOEA (Bad diarrhea), VOMITING (vomiting) and PYREXIA (fever). On 01-Nov-2023, the patient experienced HYPERHIDROSIS (Hot Sweats) and HEADACHE (she has a headache without fever). At the time of the report, HYPERHIDROSIS (Hot Sweats) outcome was unknown and DIARRHOEA (Bad diarrhea), VOMITING (vomiting), PYREXIA (fever) and HEADACHE (she has a headache without fever) was resolving.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication not reported.   The patient had vaccine on 26 Oct 2023 and 30 hours after that night of 27 Oct 2023 had a lousy, bad diarrhea, vomiting and fever. They can't figure out if this was due to the vaccine or she just caught a virus. On 1 Nov 2023, she was generally feeling good, but she had a headache without fever and hot sweats.  Treatment medication not reported.
Patient called 9/19/22 he received moderna bival booster on 9/15/22 he had a rash start on left arm spread to right arm by Friday it was all over red bumpy rash. He contacted primary care their secretary told him to call us. I counseled him to seek medical attention for the rash either at urgent care of primary md. He said he has tried benadryl it does help but it causes too much drowsiness to take constantly.
pt recvd vax;devel nodule at dtp inject site on 18sep;given augmentin & soaks;referred to MD;tx w/ keflex,flu ultrasound;dimple noted in lt thigh22jun94;lesion enlarged;surgical removed 12dec94 or cyst;
Woke up  early in the morning with 150 bpm pulse, endured for hour; underwent cardioversion; released from ER by 6:30 a.m.
Patient complained of excruciating, radiating pain in lower back that shot down to her legs along with tingling followed by weakness in her legs of which the patient said she decided to lay down cause she felt like she was going to fall because she couldn't move her legs. Patient laid down with head elevated and continued to state that she felt excruciating pain that continued in back and legs. EMS came and patient was taken to Hospital. Patient was contacted on 10/10/2020 5:00pm via telephone for follow up. Pt stated that Hospital discharged her with a diagnosis of chronic pain, no other interventions given. Patient stated that she can walk but is being cautious and no longer in pain.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. Medical history and drug reactions or allergies were not specified. On unknown dates in 2014, reported as from 10-JUN-2014 to 18-JUL-2014, an unspecified number of patients were vaccinated with VAQTA (dose number, dose, route and lot number were not reported), which were improperly stored. No adverse events were reported. Concomitant medications were not specified. Follow up was received from a medical assistant and refers to a 17 years old patient of unknown gender. On 10-JUN-2014 the patient was vaccinated with a dose of VAQTA lot # K000943 and expiry date 24-SEP-2016 (dose, route not reported) that on 10-JUN-2014 had been exposed to 51 degrees Fahrenheit for 51 minutes. This is one of several reports received from the same reporter. Additional information is not expected as no follow up was obtained.
I experienced body ached and high blood pressure after my vaccine. I also had difficulty walking due to my shoulder pain, hip and leg pain. I went to see my doctor who told me to take Tylenol for pain. A bone scan was performed due to my pain and showed arthritis.  I also received physical therapy two sessions. I can say that my symptoms also started on my first vaccine, but I did not think nothing of it at that time. I continue with my hip and leg pain today and muscular body aches.
day after vaccine was extremely tired and both hands were frozen cold, following day woke up with clogged right ear and I had vaccine shot in right arm. by end of day, I was feeling much better and ear was unclogged
The pt experienced a fever of 101 axillary and 102.6 rectally for 4-5 days. Also had slight mild nasal congestion to develop after. The pt had an office visit on 9/20/00. No other URI symptoms.
Patient and mother of child presented for their scheduled appointments for  COVID19 booster shots. , MOC thought booster was approved for 15yr old, vaccinator aware of  age after administration.. Pt monitored for 20 minutes , no s/sx of side effects at that time. MOC called URGENT CARE hotline , around 12:30pm 12/21/21  MOC states the child with headache, low grade fever 99.1, chills, and bodyaches. MOC denies difficulty breathing  or sob. MOC states the child appears weak. MOC  took the child to the ED. Followed up with MOC 12/22/21  child is side effect free and has returned to school today with no issues.
Severe allergic reaction, sore throat, itchy throat, body rash, dizziness, fatigue, anxious. All symptoms have happened between the day of the injection shot.
This spontaneous report as received from CDC (Centers for Disease Control) via company representative refers to 53 patients of unknown age and gender. On an unknown date these patients was vaccinated with GARDASIL (lot#, expiration date, dose, route not reported). These patients died after receipt of the vaccine. The causes of death were unknown. Additional information has been requested.
Patient experience tingling/prickling on side of face, in fingers, and toes.  This reaction had been going on for several hours before we were notified.  Patient also experienced racing heartbeat for about a minute several hours after receiving vaccination.
Long term 2 or 3 months extreme weakness after the 2nd shot; Long term 2 or 3 months of extreme fatigue after the 2nd shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Long term 2 or 3 months extreme weakness after the 2nd shot) and FATIGUE (Long term 2 or 3 months of extreme fatigue after the 2nd shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Long term 2 or 3 months extreme weakness after the 2nd shot) and FATIGUE (Long term 2 or 3 months of extreme fatigue after the 2nd shot). At the time of the report, ASTHENIA (Long term 2 or 3 months extreme weakness after the 2nd shot) and FATIGUE (Long term 2 or 3 months of extreme fatigue after the 2nd shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. No treatment details were provided by the reporter.     Reporter did not allow further contact
I developed facial rashes that is spreading  down  The rashes are painful to touch. Feels inflamed
Headache, no treatment, from approximately 18-48hrs Redness, swelling, pain near (not at) injection site for at least 5 days, no treatment
Fever, leg soreness, migraine. Lasted until 10:30 PM on 4/1/2021
"Covid arm"  began Saturday afternoon on 2/6/21 with itching, tenderness, warm to the touch, red, swollen raised area that was solid/hard and 2 inches in diameter.  I also had a metallic taste in my mouth that lasted for 3 days.  I took an antihistamine for 3 days.  On the 2nd day, the red area lightened and swelling, itching  decreased.  On the 3rd day he diameter of the affected area was now 3.5 inches with the center of outbreak  clearing but still red "rash"  around the perimeter (measuring about 0.5 inch.  By the end of the 3rd day, the rash was almost gone and completely gone on the 4th day.  I had this same metallic taste in my mouth almost immediately after the first vaccination on 1/30/21.  This lasted about 14+ hours. It was gone the next morning.
Presented to ED w/ generalized weakness and hypotension 10/15; admitted for acute renal failure and COVID-19. 10/15 - tx w/ Vit C & Zinc; initially she did not require supplemental oxygen.  However later during admission her respiratory status; declined slightly and she was placed on 2 L oxygen by nasal cannula; pt dc'd on steroids & supplemental O2.
Presented to Immediate Care Ctr with sinus problems-headaches, sore throat, cough, myalgias, sinus pressure, nasal congestion, and nasal drainage.  Primary symptoms did not include fever, fatigue, wheezing, or shortness of breath.
The patient had been asked to stay for observation and the pharmacist located him seated.  He was slow to respond when pharmacist was trying to give him written information on the vaccine and stated he was dizzy.  His mother took note of the conversation and recognized he was not acting normal and called EMS.  During this time he was given a glass of water to drink, his eyes initially looked glazed over but patient remained conscious although very slow to respond.  He also broke out in a sweat.  He stated that his throat was not closing and there were no signs of swelling around his lips or mouth observable.  He remained seated and revived after the drink of water stating he felt better.  Emergency personnel arrived and took him to the ambulance to check his vitals.  Family members reported low blood glucose levels.  The patient was not transported.
Post vax, devel redness, swelling at inject site. Saw dr. Warm soaks didn't help. Elbow below inject site sore.
Fever; Chills; Body aches; Headaches; Heartburn; This is a spontaneous report from a contactable healthcare professional. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 22Apr2021 (at the age of 31-year-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 31-year-old) as a single dose for COVID-19 immunization. On 22Apr2021, the patient experienced fever, chills, body aches, headaches and heartburn. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, body aches, headaches and heartburn was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Headache, Myalgia,  pain and swelling injection site, chills, fatigue,  metallic taste, general stiffness Narrative:
Felt knot in throat, difficulty swallowing and felt tingling left cheek and lips. Upper and lower lips swollen on left side. Took diphenhydramine 50 mg and continued this dose q 6 h for approximately 24 hours.  Lips still swollen at noon 10/2/2010; all sx resolved by approximately 6pm 10/2/2010.
1. fever ranging from 100.8 to 103.5. 24 hours. Treated with Tylenol 2. dizziness. No treatment. Just rest 3. Injection site reaction. Large red reaction, grew in 24 hours, pain increased in 24 hours.  Long term results pending as of 2/9/2022
I have had a severe skin breakout on my right thigh bumps that appeared after a week and are still there. In addition severe pain in my lower back on the left side which was there before the shot. Also, I have been languish and tired since the shot.
Booster dose given 3 months too early. Patient received second COVID-19 shot in November, and  given booster in January.
I have extreme fatigue after receiving this vaccination. I did not realize that it had anything similar to do with monoclonal antibiodies, for which I have suffered horrible fatigue from in the past (Prolia).  I am not sure if my symptoms started before 02/24/2021, however that is when it became overwhelming.  After doing some research on the Moderna vaccination and how it affects your mRNA (just like monoclonal antibiodies), that I realized I probably should have not received the second vaccination. (My past experience with Prolia was similar - I was fine with the first injection, but every injection I received after that made me have overwhelming fatigue, and I had to discontinue the medication.)
Rash, over body/trunk with erythema around site, approx 9-10 post-vaccination  a/p: erythema multiforme, given allegra with resolution in 4-5 days
Information has been received from a physician concerning a recent increase in chicken pox outbreaks with some of her patients that have received the first dose of varicella virus vaccine live (Oka/Merck). Representative had no additional information. There was no product quality complaint. This is one report of several from the same source. Additional information is expected.
Started with a harsh cough soon to be followed by vomiting due to excessive coughing; fever; chills; muscle cramps in legs; dizziness too severe to stand up, so had to stay laying down.
Sore arm almost immediately.  Painful red welt for 3 days.  Fever of 101 12 hours after vaccination.  Fever of102 degrees 24 hours after injection lasting 24 hours. Muscle spasms in my left leg for roughly 12 hours beginning roughly 12 hours after injection.
below temperature excursion; This case was reported by a physician via call center representative and described the occurrence of incorrect storage of drug in a 31-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number 3SE27, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 17th October 2021, the patient received Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional information was provided as follow: The patient was the reporting physician's son in law. The physician reported a below temperature excursion at 26.3 degree F for Fluarix QIV and it was already administered to a patient. The reporter consented to follow up.
pt seen in ER for wound while @ work;wounds to face & chest were treated along w/DT;pt devel 3inch diameter red, swollen, warm area @ site of inj w/pain, h/a & stiff neck;
rash on face and trunk, mild fever, irritability - also 4 hours constant crying on 5/19/03 Nurse practitioner visit on 5/20/03 - Prescribed Hydramine12.5/5ml - 1/4 tsp every 6 hours
Information has been received from a registered nurse concerning her husband. Additional information was received from a VAERS form via another company. A 54 year old male with sarcoidosis, migraine headaches, renal calculi, penicillin allergy and erythromycin allergy on 05-OCT-2006 was vaccinated with a dose of Pneumovax 23 (0.5 ml) (lot # 651332/1049F), subcutaneously (also reported as intramuscularly), in the right deltoid back of arm. Concomitant therapy that day included a dose of FLUZONE (lot # 112199AA); ("many" previous doses was reported), in the left deltoid. Other concomitant therapy included oxycodone, INDERAL and albuterol. The nurse stated that her husband received Pneumovax 23 in his right arm and the FLUZONE in his left arm. However, the chart documented Pneumovax 23 in the left arm and FLUZONE in the right arm. The nurse added that the vaccine administered in the right arm was placed "low on the back of the arm near the elbow." On 06-OCT-2006 the patient complained of pain, erythema, and edema at the site of the injection in the right arm and was examined by his physician that day. The physician diagnosed an allergic reaction and prescribed BENADRYL with ice compresses. On 10-OCT-2006 the edema of the right arm extended to the wrist. The patient was examinated by his physician on that day and was prescribed a MEDROL dose pack. The patient had elected not to take the MEDROL at that time. The physician had suggested an allergy consult to determine if the patient exhibited allergy to either vaccine. It was also reported that on 05-OCT-2006 the patient's right arm lower towards back began to hurt immediately. It became red, hot, swollen from upper arm then spread towards then to the wrist, then it began itching. At the time of the report it was still tender to the touch. At the time of the report, the patient had not recovered. Additional information has been requested.
Self-reported ADEs started day after SHINGRIX vaccine, lasted 3-4 days per patient. Erythema and swelling at injection site, headache, dizziness, nausea/vomiting/diarrhea, tinnitus, drowsiness, hypoglycemia (<50 mg/dL).